{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:40:22Z","timestamp":1763642422043,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clon.2018.06.007","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T06:10:38Z","timestamp":1530339038000},"page":"534-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Short-term Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"30","author":[{"given":"W.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gomez-Iturriaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nikapota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6\u20137","key":"10.1016\/j.clon.2018.06.007_bib1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.canrad.2008.07.012","article-title":"High dose rate brachytherapy for prostate cancer","volume":"12","author":"Hoskin","year":"2008","journal-title":"Cancer Radiother"},{"issue":"4","key":"10.1016\/j.clon.2018.06.007_bib2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2015.07.2290","article-title":"High-dose-rate monotherapy for localized prostate cancer: 10-year results","volume":"94","author":"Hauswald","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.clon.2018.06.007_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.clon.2006.04.005","article-title":"High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer","volume":"18","author":"Chin","year":"2006","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2018.06.007_bib4","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ijrobp.2010.10.015","article-title":"High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer","volume":"81","author":"Demanes","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2018.06.007_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijrobp.2012.07.004","article-title":"High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results","volume":"85","author":"Zamboglou","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.clon.2018.06.007_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clon.2015.05.001","article-title":"Acute and late bowel toxicity in radiotherapy patients with inflammatory bowel disease: a systematic review","volume":"27","author":"Tromp","year":"2015","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.clon.2018.06.007_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clon.2004.12.005","article-title":"The emerging role of high-dose-rate brachytherapy for prostate cancer","volume":"17","author":"Morton","year":"2005","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2018.06.007_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0360-3016(97)00583-X","article-title":"Prostate brachytherapy in patients with inflammatory bowel disease","volume":"40","author":"Grann","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2018.06.007_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijrobp.2006.05.027","article-title":"Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease","volume":"66","author":"Peters","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2018.06.007_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brachy.2012.04.008","article-title":"Toxicity after (125)I prostate brachytherapy in patients with inflammatory bowel disease","volume":"12","author":"Pai","year":"2013","journal-title":"Brachytherapy"},{"issue":"33","key":"10.1016\/j.clon.2018.06.007_bib11","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1200\/JCO.2006.07.9954","article-title":"Patient and treatment factors associated with complications after prostate brachytherapy","volume":"24","author":"Chen","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.clon.2018.06.007_bib12","first-page":"1953","article-title":"Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer","volume":"173","author":"Chrouser","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.clon.2018.06.007_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2018.06.007_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.v19.i2.185","article-title":"Gastrointestinal radiation injury: symptoms, risk factors and mechanisms","volume":"19","author":"Shadad","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clon.2018.06.007_bib15","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.prro.2014.09.004","article-title":"Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: patient selection and dosimetric parameters with modern treatment techniques","volume":"5","author":"Murphy","year":"2015","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"10.1016\/j.clon.2018.06.007_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1667\/RR14272.1","article-title":"GI consequences of cancer treatment: a clinical perspective","volume":"185","author":"Andreyev","year":"2016","journal-title":"Radiat Res"},{"issue":"4","key":"10.1016\/j.clon.2018.06.007_bib17","first-page":"119","article-title":"Patient-reported outcomes vs. clinician symptom reporting during chemoradiation for rectal cancer","volume":"5","author":"Flores","year":"2012","journal-title":"Gastrointest Cancer Res"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655518302905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655518302905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:44:51Z","timestamp":1760543091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655518302905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0936655518302905"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2018.06.007","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2018.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}